Navidea Biopharmaceuticals, Inc.
425 Metro Place North
Ste 450
Dublin, OH 43017
Patents
Correspondent
Use of 99mTc-tilmanocept and related molecular constructs for identifying and diagnosing malignant tumors and for monitoring therapeutic anti-tumor interventions
X0Patent Application No.16041673, Filed July 20, 2018
A1Application Publication No. 20190022259, Issued January 24, 2019
Third party AI contribution in government documents
Possible
Document content is reproduced directly from government sources. Some filings in our database may themselves contain AI-generated content submitted by third parties to government agencies.
